Indoco Profits Triple In First Quarter

As FDA Approves Indian Firm’s Rival To Eli Lilly’s Zyprexa

 
• By Akriti Seth
  
Growth
India’s Indoco is showing steady growth • Source: Shutterstock

More from Generics

More from Products